Barriers to natural interchange of biologically active material between Earth and Mars

1986 ◽  
Vol 16 (3-4) ◽  
pp. 410-411 ◽  
Author(s):  
Benton C. Clark
1960 ◽  
Vol XXXV (II) ◽  
pp. 225-234 ◽  
Author(s):  
R. Bourrillon ◽  
R. Got ◽  
R. Marcy

ABSTRACT A new method for preparation of Human Menopausal Gonadotrophin involves successively alcoholic precipitation, kaolin adsorption and chromatography on ion exchangers. A highly active material is obtained which corresponds to 1 mg per litre of urine and has an activity of 1 mouse uterus unit at a dose of 0.003 mg. This gonadotrophin possesses both follicle stimulating and luteinizing activities in hypophysectomized female rats, by histological study. It contains 13 % hexose, 10% hexosamine and 8.5 % sialic acid. A further purification, by zone electrophoresis on starch, gives a final product, biologically active at 0.001 mg, which behaves as an homogenous substance in free electrophoresis with mobility −4.76 × 10−5 at pH 8.6.


1994 ◽  
Vol 72 (02) ◽  
pp. 275-280 ◽  
Author(s):  
David Brieger ◽  
Joan Dawes

SummaryIt is widely reported that persistent anti-Xa activity follows administration of low molecular weight heparins. To identify the effectors of this activity we have injected 125I-labelled Enoxaparin sodium into rabbits and subsequently analysed the circulating radiolabelled material and anti-Xa activity by affinity and size exclusion chromatography. Antithrombin III-binding material derived from the injected drug was responsible for all the anti-Xa amidolytic activity. At early times after injection additional anticoagulant activity which was largely attributable to tissue factor pathway inhibitor was measured by the Heptest clotting assay after removal of glycosaminoglycans from plasma samples. Small radiolabelled fragments, including penta/hexasaccharide with affinity for antithrombin III, were detectable in the circulation 1 week later, and sulphated oligosaccharides persisted for 3-4 weeks. Significant quantities of radiolabel remained in the liver and kidney several weeks post-injection; these organs may sequester some of the injected drug and give rise to circulating biologically active material by degradation and secretion of catabolic products into the plasma.


1988 ◽  
Vol 8 (6) ◽  
pp. 562-566 ◽  
Author(s):  
Martin Frenz ◽  
Fabien Mathezloic ◽  
Michael H. S. Stoffel ◽  
Adrian D. Zweig ◽  
Valerio Romano ◽  
...  

1977 ◽  
Vol 23 (4) ◽  
pp. 677-682 ◽  
Author(s):  
Juergen Zapf ◽  
Ueli Kaufmann ◽  
Eugen J Eigenmann ◽  
E Rudolf Froesch

Abstract We describe a sensitive protein-binding assay for non-suppressible insulin-like activity in human serum. It can detect as little as 0.2 microunits (corresponding to 0.5 ng) of the activity in 0.4 ml of the assay mixture. It is measured in a low-molecular-weight fraction (termed "biological material") obtained by chromatography of serum on Se¬phadex G-50 in 1 mol/liter acetic acid. This fraction has been shown earlier to contain nearly all this biologically active material that is present in serum. A partially purified carrier protein from human serum is used as the binding protein; different concentrations of a partially purified preparation of material with the activity serve as standards, which compete with 1251-labeled tracer for binding. Bio¬logical material dilutes more or less in parallel with the standard over a 10-fold concentration range. In the chro¬matographed serum fractions, displacing activity appears between 50 and 80% bed volume, with the peak at 60%, and coincides with the distribution and the peak of radio¬activity obtained by chromatography of tracer. A good correlation (γ = 0.88) is observed between the values determined for this activity in the rat fat-pad assay and the protein-binding assay, although the latter yields about twofold higher results (160 ± 37 milliunits/liter vs. 345 ± 65 milliunits/liter, mean values for 18 normal sera). Values determined in the protein-binding assay are decreased in hypopituitary patients (183 ± 27 milliunits/liter) and in¬creased in acromegalics (486 ± 88 milliunits/liter), in accord with the results of the bioassay (68 ± 21 milli-units/liter for hypopituitary patients, 293 ± 53 for acro¬megalics).


1980 ◽  
Vol 23 (4) ◽  
pp. 1012-1015
Author(s):  
Joe M. Bunn ◽  
Wiley H. Henson ◽  
Jr. ◽  
Linus R. Walton

Sign in / Sign up

Export Citation Format

Share Document